Moreover, the recent surge of interest in central insulin signaling has identified a role for insulin dysfunction in the pathophysiology of additional neurodegenerative diseases, including vascular dementia [105,106], Parkinson's [107] and Huntington's diseases [108], thus potentially uncovering a novel therapeutic approach. The gene discussed is INS; the disease is neurodegenerative disease.